• Wed, February 7, 2024

by: WOPRAI

Gil Luria Maintained (AAPL) at Hold with Increased Target to $200 on, Feb 7th, 2024

by: WOPRAI

Andrew Kaplowitz Maintained (ACM) at Strong Buy with Increased Target to $107 on, Feb 7th, 2024

by: WOPRAI

Arthur Nagorny Reiterated (ACM) at Buy and Held Target at $109 on, Feb 7th, 2024

by: WOPRAI

Tom Nikic Maintained (VFC) at Hold with Decreased Target to $16 on, Feb 7th, 2024

by: WOPRAI

Brooke Roach Downgraded (VFC) to Hold and Held Target at $14 on, Feb 7th, 2024

by: WOPRAI

Ike Boruchow Maintained (VFC) at Hold with Decreased Target to $14 on, Feb 7th, 2024

by: WOPRAI

Jim Duffy Maintained (VFC) at Strong Buy with Decreased Target to $22 on, Feb 7th, 2024

by: WOPRAI

Lorraine Hutchinson Maintained (VFC) at Sell with Decreased Target to $13 on, Feb 7th, 2024

by: WOPRAI

Jonathan Komp Maintained (VFC) at Hold with Decreased Target to $16 on, Feb 7th, 2024

by: WOPRAI

Nick Setyan Maintained (TXRH) at Buy with Increased Target to $145 on, Feb 7th, 2024

by: WOPRAI

Andrew Bond Maintained (TW) at Strong Buy with Increased Target to $112 on, Feb 7th, 2024

by: WOPRAI

Michael Cyprys Maintained (TW) at Buy with Increased Target to $122 on, Feb 7th, 2024

by: WOPRAI

Vincent Andrews Maintained (APD) at Hold with Decreased Target to $240 on, Feb 7th, 2024

by: WOPRAI

Aaron Rakers Maintained (ANET) at Buy with Increased Target to $310 on, Feb 7th, 2024

by: WOPRAI

Dave Kang Maintained (AVNW) at Strong Buy with Decreased Target to $59 on, Feb 7th, 2024

by: WOPRAI

Erik Suppiger Reiterated (AVNW) at Buy and Held Target at $50 on, Feb 7th, 2024

by: WOPRAI

Hamed Khorsand Maintained (ATEN) at Strong Buy with Increased Target to $17 on, Feb 7th, 2024

by: WOPRAI

Ryan Macwilliams Maintained (AUDC) at Sell with Increased Target to $12 on, Feb 7th, 2024

by: WOPRAI

Beth Reed Maintained (ASO) at Strong Buy with Increased Target to $77 on, Feb 7th, 2024

by: WOPRAI

Joe O"Dea Maintained (CARR) at Hold with Decreased Target to $57 on, Feb 7th, 2024

by: WOPRAI

Deane Dray Maintained (CARR) at Buy with Decreased Target to $60 on, Feb 7th, 2024

by: WOPRAI

Manan Gosalia Maintained (CADE) at Hold with Increased Target to $27 on, Feb 7th, 2024

by: WOPRAI

Manan Gosalia Maintained (CBSH) at Hold with Increased Target to $55 on, Feb 7th, 2024

by: WOPRAI

Chase Knickerbocker Initiated (ACST) at Strong Buy and Held Target at $6 on, Feb 7th, 2024

by: WOPRAI

Joe Quatrochi Maintained (AEIS) at Hold with Decreased Target to $97 on, Feb 7th, 2024

by: WOPRAI

Clarke Jeffries Reiterated (AZPN) at Hold and Held Target at $196 on, Feb 7th, 2024

by: WOPRAI

Trey Grooms Maintained (AZEK) at Buy with Increased Target to $50 on, Feb 7th, 2024

by: WOPRAI

Mike Dahl Maintained (AZEK) at Buy with Increased Target to $49 on, Feb 7th, 2024

by: WOPRAI

Keith Hughes Maintained (AZEK) at Strong Buy with Increased Target to $48 on, Feb 7th, 2024

by: WOPRAI

Stanley Elliott Maintained (AZEK) at Strong Buy with Increased Target to $52 on, Feb 7th, 2024

by: WOPRAI

Alex Rygiel Maintained (AZEK) at Strong Buy with Increased Target to $50 on, Feb 7th, 2024

by: WOPRAI

Yi Fu Lee Reiterated (BBAI) at Buy and Held Target at $3 on, Feb 7th, 2024

by: WOPRAI

Steve Barger Maintained (AME) at Buy with Increased Target to $182 on, Feb 7th, 2024

by: WOPRAI

Deane Dray Maintained (AME) at Buy with Decreased Target to $188 on, Feb 7th, 2024

by: WOPRAI

Salveen Richter Maintained (AMGN) at Strong Buy with Increased Target to $350 on, Feb 7th, 2024

by: WOPRAI

Gregory Renza Maintained (AMGN) at Buy with Increased Target to $329 on, Feb 7th, 2024

by: WOPRAI

Terence Flynn Maintained (AMGN) at Hold with Decreased Target to $278 on, Feb 7th, 2024

by: WOPRAI

Charles Neivert Initiated (ALTM) at Sell and Held Target at $4.5 on, Feb 7th, 2024

by: WOPRAI

Steven Fisher Maintained (AGCO) at Hold with Decreased Target to $138 on, Feb 7th, 2024

by: WOPRAI

Brent Bracelin Reiterated (BILL) at Buy and Held Target at $95 on, Feb 7th, 2024

by: WOPRAI

Chuck Grom Downgraded (BJ) to Hold and Held Target at $70 on, Feb 7th, 2024

by: WOPRAI

Nick Setyan Maintained (WEN) at Hold with Decreased Target to $20 on, Feb 7th, 2024

by: WOPRAI

Bascome Majors Maintained (WERN) at Hold with Decreased Target to $40 on, Feb 7th, 2024

by: WOPRAI

Ravi Shanker Maintained (WERN) at Buy with Decreased Target to $59 on, Feb 7th, 2024

by: WOPRAI

Jack Atkins Reiterated (WERN) at Buy and Held Target at $49 on, Feb 7th, 2024

by: WOPRAI

Manan Gosalia Maintained (WBS) at Buy with Increased Target to $61 on, Feb 7th, 2024

by: WOPRAI

Daniel Arias Maintained (WAT) at Hold with Increased Target to $330 on, Feb 7th, 2024

by: WOPRAI

Manan Gosalia Maintained (VLY) at Sell with Increased Target to $9 on, Feb 7th, 2024

Michael Ulz Maintained (ARWR) at Hold with Increased Target to $36 on, Feb 7th, 2024

Michael Ulz of Morgan Stanley, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $34 to $36 on, Feb 7th, 2024.

Michael has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael

  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $37 on, Tuesday, January 2nd, 2024

Like: 👍